Goldline Pharmaceutical IPO Allotment Status
Goldline Pharmaceutical IPO Pages
Goldline Pharmaceutical has already listed
Goldline Pharmaceutical listed on BSE SME on 18 May 2026. Allotment refunds and credits should already be reflected in your bank and demat accounts.
For complete listing details and historical data, see Goldline Pharmaceutical IPO →
Frequently Asked Questions
When will Goldline Pharmaceutical IPO allotment be finalised?
The allotment date for Goldline Pharmaceutical IPO has not yet been confirmed. In India, allotment is generally finalised 2 working days after the IPO closes. Check this page or the issuer's prospectus for updates.
What identifiers do I need to check Goldline Pharmaceutical IPO allotment?
You need any one of: PAN number, IPO application number (issued by your broker), or DP/Client ID. PAN is the most reliable as it works across all registrar portals.
When are Goldline Pharmaceutical IPO shares credited to my demat account?
For allotted applicants, shares are credited 1 working day before listing — around 17 May 2026 for Goldline Pharmaceutical. You can verify the credit in your demat holdings (NSDL/CDSL) via your broker.
What if I don't get IPO allotment?
Funds blocked via UPI / ASBA are released back to your bank account within 1-2 working days of the allotment date. If your funds are not unblocked, contact your bank or sponsor bank.
Can I check Goldline Pharmaceutical IPO allotment without a PAN?
No. PAN is mandatory for IPO applications and is the primary way registrars and exchanges identify your application. If you applied through a broker, your application number can also be used as an alternative on the registrar's portal.